SCHEMBL25753482

SCHEMBL25753482

O=Cc1cccn1Cc1ccncc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.48
▸ HDAC8 Q9BY41 2/20 0.47
▸ HDAC6 Q9UBN7 2/20 0.47
▸ HDAC3 O15379 1/20 0.46
▸ HDAC4 P56524 1/20 0.46
▸ HDAC1 Q13547 1/20 0.46
▸ HDAC7 Q8WUI4 1/20 0.46
▸ HDAC2 Q92769 1/20 0.46
▸ HDAC10 Q969S8 1/20 0.46
▸ HDAC11 Q96DB2 1/20 0.46
▸ HDAC9 Q9UKV0 1/20 0.46
▸ HDAC5 Q9UQL6 1/20 0.46
▸ CYP11B1 P15538 2/20 0.43
▸ CYP11B2 P19099 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ HTT P42858 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ TRIM24 O15164 1/20 0.40
▸ TRIM33 Q9UPN9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1244152 0.84 ALDH1A1 (0.55) ALDH1A1HDAC8HDAC6HTTSMN1; SMN2
SCHEMBL9400665 0.82 VEGFA (0.56) ALDH1A1CYP11B1CYP11B2HTTSMN1; SMN2
SCHEMBL28469757 0.82 ALDH1A1 (0.54) ALDH1A1CYP11B1CYP11B2HTTSMN1; SMN2
SCHEMBL25342233 0.82 HDAC3 (0.49) ALDH1A1HDAC8HDAC6HDAC3HDAC4
SCHEMBL28477450 0.81 ALDH1A1 (0.49) ALDH1A1HDAC8HDAC6HDAC3HDAC4
SCHEMBL28469317 0.81 MAPT (0.55) ALDH1A1HDAC8HDAC6PKMSMN1; SMN2
SCHEMBL17894535 0.80 ALDH1A1 (0.55) ALDH1A1HTTSMN1; SMN2KDM4EATM
SCHEMBL18002172 0.79 HDAC8 (0.54) ALDH1A1HDAC8HDAC6CYP11B1CYP11B2
SCHEMBL6057467 0.77 DRD2 (0.54) ALDH1A1HDAC8HDAC6HDAC1SMN1; SMN2
SCHEMBL1609235 0.77 ALDH1A1 (0.60) ALDH1A1HDAC8HDAC6HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4205741-A1 USE OF COMPOUND AS CYP2E1 INHIBITOR Shanghai Ling Xi Biotechnology Development Co., Ltd. (CN) 2023-07-05 — — EP disclosed
Send feedback